Resistance patterns to anti-PD-1 therapy in metastatic melanoma

被引：3

作者：

Ozgun, Alpaslan

Sondak, Vernon K.

Markowitz, Joseph

机构：

[1] Univ S Florida, Morsani Coll Med, Moffitt Canc Ctr, Dept Cutaneous Oncol, Tampa, FL USA

[2] Univ S Florida, Morsani Coll Med, Dept Oncol Sci, Dept Cutaneous Oncol, Tampa, FL USA

来源：

CHINESE CLINICAL ONCOLOGY | 2016年 / 5卷 / 06期

关键词：

D O I：

10.21037/cco.2016.08.01

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[41] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
Parakh, Sagun
Park, John J.
Mendis, Shehara
Rai, Rajat
Xu, Wen
Lo, Serigne
Drummond, Martin
Rowe, Catherine
Wong, Annie
McArthur, Grant
Haydon, Andrew
Andrews, Miles C.
Cebon, Jonathan
Guminski, Alex
Kefford, Richard F.
Long, Georgina V.
Menzies, Alexander M.
Klein, Oliver
Carlino, Matteo S.
[J]. BRITISH JOURNAL OF CANCER, 2017, 116 (12) : 1558 - 1563
[42] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
Park, J. J.
Parakh, S.
Mendis, S.
Rai, R.
Lo, S.
Haydon, A.
Andrews, M. C.
Cebon, J.
Guminski, A.
Kefford, R.
Long, G. V.
Menzies, A. M.
Klein, O.
Carlino, M. S.
[J]. ANNALS OF ONCOLOGY, 2016, 27
[43] Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy
Nalan Akgul Babacan
Zeynep Eroglu
[J]. Current Oncology Reports, 2020, 22
[44] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
Sagun Parakh
John J Park
Shehara Mendis
Rajat Rai
Wen Xu
Serigne Lo
Martin Drummond
Catherine Rowe
Annie Wong
Grant McArthur
Andrew Haydon
Miles C Andrews
Jonathan Cebon
Alex Guminski
Richard F Kefford
Georgina V Long
Alexander M Menzies
Oliver Klein
Matteo S Carlino
[J]. British Journal of Cancer, 2017, 116 : 1558 - 1563
[45] Low-dose ipilimumab combined with anti-PD-1 immunotherapy in patients with metastatic melanoma following anti-PD-1 treatment failure
Klee, Gina
Kurzhals, Jonas
Hagelstein, Victoria
Zillikens, Detlef
Recke, Andreas
Langan, Ewan A.
Terheyden, Patrick
[J]. MELANOMA RESEARCH, 2021, 31 (05) : 464 - 471
[46] Safety and Activity of Combined Radiation Therapy (RT) and Anti-PD-1 Antibodies (PD-1) in Patients (pts) With Metastatic Melanoma
Liniker, E.
Kong, B.
Menzies, A. M.
Cooper, A. J.
Kefford, R. F.
Fogarty, G. B.
Guminski, A.
Carlino, M. S.
Wang, T. W.
Long, G. V.
Hong, A.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E635 - E635
[47] Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy
da Silva, Ines Pires
Lo, Serigne
Quek, Camelia
Gonzalez, Maria
Carlino, Matteo S.
Long, Georgina, V
Menzies, Alexander M.
[J]. CANCER, 2020, 126 (01) : 86 - 97
[48] Rechallenge with combination ipilimumab and anti-PD-1 (IPI+PD1) in metastatic melanoma after acquired resistance to IPI+PD1 immunotherapy
Hepner, A.
Carlino, M. S.
Johnson, D. B.
Gerard, C. L.
Lo, S.
Pallan, L.
Silva, I. D.
Michielin, O. A.
Long, G. V.
Menzies, A. M.
[J]. ANNALS OF ONCOLOGY, 2019, 30
[49] Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
George, Suzanne
Miao, Diana
Demetri, George D.
Adeegbe, Dennis
Rodig, Scott J.
Shukla, Sachet
Lipschitz, Mikel
Amin-Mansour, Ali
Raut, Chandrajit P.
Carter, Scott L.
Hammerman, Peter
Freeman, Gordon J.
Wu, Catherine J.
Ott, Patrick A.
Wong, Kwok-Kin
Van Allen, Eliezer M.
[J]. IMMUNITY, 2017, 46 (02) : 197 - 204
[50] Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
Diem, S.
Kasenda, B.
Spain, L.
Martin-Liberal, J.
Marconcini, R.
Gore, M.
Larkin, J.
[J]. BRITISH JOURNAL OF CANCER, 2016, 114 (03) : 256 - 261

← 1 2 3 4 5 →